-
Next Set of Vioxx Trials in New Jersey Assigned Court Dates By Judge Higbee
New Jersey Judge Sets A February 27, 2006 Trial Date for Next NJ Vioxx Case In late November 2005 New Jersey Superior Court Judge Carol Higbee announced that she tentatively plans to consolidate the…
-
Irvin / Plunkett v. Merck: Federal Court MDL Vioxx Trial Starts in Texas
AP Reports At Least 7,875 Vioxx Lawsuits Filed By Thanksgiving Day 2005 The first Vioxx federal trial, Irvin / Plunkett v. Merck, is scheduled to start today, November 29, 2005, in Houston, Texas. This…
-
Study On Cardiovascular Safety of Celebrex Reported at 2005 ACR Meeting
No Increased Risk Of Heart Attack Or Stroke For Patients Taking Celebrex According to a meta-analysis reported by Dr. Lee Simon, Associate Clinical Professor of Medicine at Harvard Medical School, the COX-2 specific…
-
Did GlaxoSmithKline Mislead The FDA As Regards Asthma Drug Serevent?
Consumer Group Public Citizen Allegation In Medical Journal The Lancet In an early October 2005 edition of The Lancet, a British medical journal, a published letter by the American consumer group Public Citizen accused…
-
Serevent, Advair, and Foradil: Increased Risk of Severe Asthma Episodes and Death
FDA MedWatch Alert About LABA Asthma Drugs Follows Health Canada Warning In October 2005 On November 18, 2005 the FDA issued a MedWatch alert regarding Serevent, Advair, and Foradil to inform doctors and patients…
-
“Black-box” Warnings On Drug Labels Often Ignored By Doctors And Patients
Study Indicates Need For Better Presentation of Drug-safety Information On November 18, 2005 the medical journal Pharmacoepidemiology and Drug Safety published findings from a new study which reveals that doctors and patients, both, often…
